Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
Abstract The value of in silico methods in drug development and evaluation has been demonstrated repeatedly and convincingly. While their benefits are now unanimously recognized, international standards for their evaluation, accepted by all stakeholders involved, are still to be established. In this...
Guardado en:
Autores principales: | Flora T. Musuamba, Ine Skottheim Rusten, Raphaëlle Lesage, Giulia Russo, Roberta Bursi, Luca Emili, Gaby Wangorsch, Efthymios Manolis, Kristin E. Karlsson, Alexander Kulesza, Eulalie Courcelles, Jean‐Pierre Boissel, Cécile F. Rousseau, Emmanuelle M. Voisin, Rossana Alessandrello, Nuno Curado, Enrico Dall’ara, Blanca Rodriguez, Francesco Pappalardo, Liesbet Geris |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97e2e67f5a5b4314bf9e9f73a5497dde |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
por: Ine Skottheim Rusten, et al.
Publicado: (2021) -
Empirical evidence on the relation between fiscal credibility and Central Bank credibility: the Brazilian case
por: Gabriel Caldas Montes, et al.
Publicado: (2019) -
Credibility and inflation targeting in Chile
por: Céspedes, Luis Felipe, et al.
Publicado: (2019) -
Independence, credibility, and communication of central banking
Publicado: (2021) -
Reputation, credibility and monetary policy effectiveness
por: Gabriel Caldas Montes
Publicado: (2009)